Mhc. Carvalho et al., THE ROLE OF THROMBOXANE-A(2) IN THE ALTERED MICROVASCULAR REACTIVITY IN 2-KIDNEY, ONE-CLIP HYPERTENSION, Endothelium, 5(3), 1997, pp. 167-178
To investigate the nature of the arachidonic acid metabolite involved
in the altered reactivity of microvessels of two-kidney, one-clip hype
rtensive rats and the possible contribution of this product to the ele
vated blood pressure levels found in two-kidney, one-clip hypertension
, mesenteric arterioles either perfused in vitro or studied in vivo we
re used along with blood pressure determinations. The decreased respon
se to acetylcholine observed was normalized by ridogrel, a thromboxane
A(2) receptor antagonist, and dazoxiben, a thromboxane A(2) synthase
inhibitor. The smooth muscle response to nitric oxide, tested with sod
ium nitroprusside, was unaltered in two-kidney, one-clip hypertensive
microvessels. Neither ridogrel nor dazoxiben modified the response to
this vasodilator. In contrast, the potentiated response to noradrenali
ne was corrected by ridogrel and dazoxiben in vitro but not in vivo. N
oradrenaline and acetylcholine increased the release of thromboxane A(
2) from the mesenteric microvessels of two-kidney, one-clip hypertensi
ve rats. Ridogrel and dazoxiben decreased but did not normalize the el
evated blood pressure of hypertensive rats. Based on these results, we
concluded that: 1) the decreased responsiveness of smooth muscle to a
cetylcholine resulted from an increase in thromboxane A(2) formation r
ather than a decrease in sensitivity to nitric oxide; 2) thromboxane A
(2) contributes to the increased noradrenaline response in mesenteric
microvessels perfused in vitro while in in vivo other blood borne vaso
active agents may also be involved since the potentiated noradrenaline
response was not corrected by inhibiting thromboxane A(2) synthesis o
r receptors; 3) in addition to thromboxane A(2), another as yet uniden
tified factor, may contribute to the elevated blood pressure in two-ki
dney, one-clip hypertension.